Corcept Therapeutics Aktie
48,80
EUR
-1,26
EUR
-2,52
%
52,03
USD
+0,94
USD
+1,84
%
Corcept Therapeutics Aktie Analyse
10.08.18 | Corcept Therapeutics Hold | Stifel, Nicolaus & Co., Inc. | |
31.05.18 | Corcept Therapeutics Hold | Stifel, Nicolaus & Co., Inc. | |
09.03.18 | Corcept Therapeutics Buy | B. Riley FBR, Inc. | |
31.08.17 | Corcept Therapeutics Buy | Stifel, Nicolaus & Co., Inc. | |
21.04.15 | Corcept Therapeutics Outperform | FBR Capital | |
02.11.09 | Corcept Therapeutics kaufen | Global Biotech Investing | |
15.08.05 | Corcept Therapeutics Buy | Punk, Ziegel & Co | |
25.04.05 | Corcept Therapeutics Outperform | Harris Nesbitt | |
Werbung
|